GENETIC TECHNOLOGIES LTD - SPON ADR 150SHS (GENE)

CUSIP: 37185R208

Q3 2015 13F Holders as of 30 Sep 2015

Type / Class
Equity / SPON ADR 150SHS
Total 13F shares
595,686
Share change
-384,007
Total reported value
$1,060,000
Price per share
$1.79
Number of holders
9
Value change
-$769,743
Number of buys
2
Number of sells
6

Quarterly Holders Quick Answers

What is CUSIP 37185R208?
CUSIP 37185R208 identifies GENE - GENETIC TECHNOLOGIES LTD - SPON ADR 150SHS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of GENETIC TECHNOLOGIES LTD - SPON ADR 150SHS (GENE) as of Q3 2015

As of 30 Sep 2015, GENETIC TECHNOLOGIES LTD - SPON ADR 150SHS (GENE) was held by 9 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 595,686 shares. The largest 9 holders included RENAISSANCE TECHNOLOGIES LLC, WOLVERINE ASSET MANAGEMENT LLC, KCG Holdings, Inc., CITADEL ADVISORS LLC, DEUTSCHE BANK AG\, Creative Planning, MORGAN STANLEY, Tower Research Capital LLC (TRC), and LADENBURG THALMANN FINANCIAL SERVICES INC. This page lists 9 institutional shareholders reporting positions in this security for the Q3 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.